{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T13:03:28Z","timestamp":1777986208615,"version":"3.51.4"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00109-022-02197-0","type":"journal-article","created":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T08:04:02Z","timestamp":1650441842000},"page":"713-722","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Nets, pulmonary arterial hypertension, and thrombo-inflammation"],"prefix":"10.1007","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7918-6842","authenticated-orcid":false,"given":"Lu\u00eds Pedro","family":"Baptista de Barros Ribeiro Dourado","sequence":"first","affiliation":[]},{"given":"M\u00e1rio","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Daniel","family":"Moreira-Gon\u00e7alves","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,4,20]]},"reference":[{"key":"2197_CR1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1055\/s-0037-1606214","volume":"38","author":"C Guignabert","year":"2017","unstructured":"Guignabert C, Dorfmuller P (2017) Pathology and pathobiology of pulmonary hypertension. Semin Respir Crit Care Med 38:571\u2013584","journal-title":"Semin Respir Crit Care Med"},{"key":"2197_CR2","doi-asserted-by":"crossref","unstructured":"Galie N, McLaughlin VV, Rubin LJ, Simonneau G (2019) An overview of the 6th World Symposium on Pulmonary Hypertension. Eur Respir J. 2019;53.","DOI":"10.1183\/13993003.02148-2018"},{"key":"2197_CR3","doi-asserted-by":"publisher","first-page":"1801887","DOI":"10.1183\/13993003.01887-2018","volume":"53","author":"M Humbert","year":"2019","unstructured":"Humbert M, Guignabert C, Bonnet S, Dorfm\u00fcller P, Klinger JR, Nicolls MR et al (2019) Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. Eur Respir J 53:1801887","journal-title":"Eur Respir J"},{"key":"2197_CR4","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1161\/CIRCULATIONAHA.109.911818","volume":"122","author":"M Humbert","year":"2010","unstructured":"Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V et al (2010) Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 122:156\u2013163","journal-title":"Circulation"},{"key":"2197_CR5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jjcc.2014.06.009","volume":"64","author":"H Matsubara","year":"2014","unstructured":"Matsubara H, Ogawa A (2014) Treatment of idiopathic\/hereditary pulmonary arterial hypertension. J Cardiol 64:243\u2013249","journal-title":"J Cardiol"},{"key":"2197_CR6","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.drudis.2014.04.001","volume":"19","author":"KL Lannan","year":"2014","unstructured":"Lannan KL, Phipps RP, White RJ (2014) Thrombosis, platelets, microparticles and PAH: more than a clot. Drug Dis Today 19:1230\u20131235","journal-title":"Drug Dis Today"},{"key":"2197_CR7","first-page":"1532","volume":"303","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS et al (2004) Neutrophil extracellular traps kill bacteria science 303:1532\u20131535","journal-title":"Neutrophil extracellular traps kill bacteria science"},{"key":"2197_CR8","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/nm.2514","volume":"17","author":"M Phillipson","year":"2011","unstructured":"Phillipson M, Kubes P (2011) The neutrophil in vascular inflammation. Nat Med 17:1381","journal-title":"Nat Med"},{"key":"2197_CR9","doi-asserted-by":"publisher","first-page":"44123","DOI":"10.1074\/jbc.M405883200","volume":"279","author":"S Martinelli","year":"2004","unstructured":"Martinelli S, Urosevic M, Daryadel A, Oberholzer PA, Baumann C, Fey MF et al (2004) Induction of genes mediating interferon-dependent extracellular trap formation during neutrophil differentiation. J Biol Chem 279:44123\u201344132","journal-title":"J Biol Chem"},{"key":"2197_CR10","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1016\/j.febslet.2010.06.006","volume":"584","author":"AK Gupta","year":"2010","unstructured":"Gupta AK, Joshi MB, Philippova M, Erne P, Hasler P, Hahn S et al (2010) Activated endothelial cells induce neutrophil extracellular traps and are susceptible to NETosis-mediated cell death. FEBS Lett 584:3193\u20133197","journal-title":"FEBS Lett"},{"key":"2197_CR11","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1161\/ATVBAHA.114.304114","volume":"34","author":"TJ Gould","year":"2014","unstructured":"Gould TJ, Vu TT, Swystun LL, Dwivedi DJ, Mai SH, Weitz JI et al (2014) Neutrophil extracellular traps promote thrombin generation through platelet-dependent and platelet-independent mechanismssignificance. Arterioscler Thromb Vasc Biol 34:1977\u20131984","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2197_CR12","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1182\/blood-2015-01-624023","volume":"126","author":"J Etulain","year":"2015","unstructured":"Etulain J, Martinod K, Wong SL, Cifuni SM, Schattner M, Wagner DD (2015) P-selectin promotes neutrophil extracellular trap formation in mice. Blood 126:242\u2013246","journal-title":"Blood"},{"key":"2197_CR13","doi-asserted-by":"publisher","first-page":"15880","DOI":"10.1073\/pnas.1005743107","volume":"107","author":"TA Fuchs","year":"2010","unstructured":"Fuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, Myers DD et al (2010) Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci 107:15880\u201315885","journal-title":"Proc Natl Acad Sci"},{"key":"2197_CR14","doi-asserted-by":"crossref","unstructured":"Aldabbous L, Abdul-Salam V, McKinnon T, Duluc L, Pepke-Zaba J, Southwood M et al (2016) Neutrophil extracellular traps promote angiogenesis: evidence from vascular pathology in pulmonary hypertension. Arteriosclerosis, thrombosis, and vascular biology. ATVBAHA. 116.307634.","DOI":"10.1161\/ATVBAHA.116.307634"},{"key":"2197_CR15","doi-asserted-by":"crossref","unstructured":"Laridan E, Denorme F, Desender L, Fran\u00e7ois O, Andersson T, Deckmyn H et al (2017) Neutrophil extracellular traps in ischemic stroke thrombi. Ann Neurol.","DOI":"10.1002\/ana.24993"},{"key":"2197_CR16","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1164\/rccm.200907-1135OC","volume":"181","author":"M Miniati","year":"2010","unstructured":"Miniati M, Fiorillo C, Becatti M, Monti S, Bottai M, Marini C et al (2010) Fibrin resistance to lysis in patients with pulmonary hypertension other than thromboembolic. Am J Respir Crit Care Med 181:992\u2013996","journal-title":"Am J Respir Crit Care Med"},{"key":"2197_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S0025-6196(12)65277-X","volume":"60","author":"J Bjornsson","year":"1985","unstructured":"Bjornsson J, Edwards WD (1985) Primary pulmonary hypertension: a histopathologic study of 80 cases. Mayo Clin Proc 60:16\u201325","journal-title":"Mayo Clin Proc"},{"key":"2197_CR18","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0012-3692(15)51873-4","volume":"130","author":"SR Johnson","year":"2006","unstructured":"Johnson SR, Granton JT, Mehta S (2006) Thrombotic arteriopathy and anticoagulation in pulmonary hypertension. Chest 130:545\u2013552","journal-title":"Chest"},{"key":"2197_CR19","doi-asserted-by":"crossref","unstructured":"Wagenvoort CA, Mulder PG (1993) Thrombotic lesions in primary plexogenic arteriopathy. Similar pathogenesis or complication? Chest. 103:844\u20139.","DOI":"10.1378\/chest.103.3.844"},{"key":"2197_CR20","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.hrtlng.2014.07.006","volume":"43","author":"MK Mojadidi","year":"2014","unstructured":"Mojadidi MK, Goodman-Meza D, Eshtehardi P, Pamerla M, Msaouel P, Roberts SC et al (2014) Thrombocytopenia is an independent predictor of mortality in pulmonary hypertension. Heart Lung 43:569\u2013573","journal-title":"Heart Lung"},{"key":"2197_CR21","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1253\/circj.CJ-11-1223","volume":"76","author":"H Taguchi","year":"2012","unstructured":"Taguchi H, Kataoka M, Yanagisawa R, Kawakami T, Tamura Y, Fukuda K et al (2012) Platelet level as a new prognostic factor for idiopathic pulmonary arterial hypertension in the era of combination therapy. Circ J 76:1494\u20131500","journal-title":"Circ J"},{"key":"2197_CR22","first-page":"395","volume":"13","author":"IC Haznedaroglu","year":"2002","unstructured":"Haznedaroglu IC, Atalar E, Ozturk MA, Ozer N, Ovunc K, Aksoyek S et al (2002) Thrombopoietin inside the pulmonary vessels in patients with and without pulmonary hypertension. Platelets 13:395\u2013399","journal-title":"Platelets"},{"key":"2197_CR23","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1080\/09537104.2018.1499890","volume":"30","author":"E Vrigkou","year":"2019","unstructured":"Vrigkou E, Tsangaris I, Bonovas S, Kopterides P, Kyriakou E, Konstantonis D et al (2019) Platelet and coagulation disorders in newly diagnosed patients with pulmonary arterial hypertension. Platelets 30:646\u2013651","journal-title":"Platelets"},{"key":"2197_CR24","doi-asserted-by":"publisher","first-page":"L512","DOI":"10.1152\/ajplung.00289.2011","volume":"302","author":"M Aytekin","year":"2012","unstructured":"Aytekin M, Aulak KS, Haserodt S, Chakravarti R, Cody J, Minai OA et al (2012) Abnormal platelet aggregation in idiopathic pulmonary arterial hypertension: role of nitric oxide. Am J Physiol Lung Cell Mol Physiol 302:L512\u2013L520","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2197_CR25","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.hlc.2014.11.025","volume":"24","author":"YG Zheng","year":"2015","unstructured":"Zheng YG, Yang T, Xiong CM, He JG, Liu ZH, Gu Q et al (2015) Platelet distribution width and mean platelet volume in idiopathic pulmonary arterial hypertension. Heart Lung Circ 24:566\u2013572","journal-title":"Heart Lung Circ"},{"key":"2197_CR26","doi-asserted-by":"publisher","first-page":"E171","DOI":"10.1177\/1076029610394438","volume":"17","author":"E Varol","year":"2011","unstructured":"Varol E, Uysal BA, Ozaydin M (2011) Platelet indices in patients with pulmonary arterial hypertension. Clin Appl Thromb Hemost 17:E171\u2013E174","journal-title":"Clin Appl Thromb Hemost"},{"key":"2197_CR27","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/0041-008X(88)90006-3","volume":"96","author":"SM White","year":"1988","unstructured":"White SM, Roth RA (1988) Pulmonary platelet sequestration is increased following monocrotaline pyrrole treatment of rats. Toxicol Appl Pharmacol 96:465\u2013475","journal-title":"Toxicol Appl Pharmacol"},{"key":"2197_CR28","first-page":"9700","volume":"8","author":"A Remkova","year":"2015","unstructured":"Remkova A, Simkova I, Valkovicova T (2015) Platelet abnormalities in chronic thromboembolic pulmonary hypertension. Int J Clin Exp Med 8:9700\u20139707","journal-title":"Int J Clin Exp Med"},{"key":"2197_CR29","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S0092-8674(03)01014-6","volume":"115","author":"DJ Walther","year":"2003","unstructured":"Walther DJ, Peter J-U, Winter S, H\u00f6ltje M, Paulmann N, Grohmann M et al (2003) Serotonylation of small GTPases is a signal transduction pathway that triggers platelet \u03b1-granule release. Cell 115:851\u2013862","journal-title":"Cell"},{"key":"2197_CR30","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/chd.12616","volume":"13","author":"T Mese","year":"2018","unstructured":"Mese T, Guven B, Yilmazer MM, Karadeniz C, Ozdemir R, Doksoz O (2018) Platelet activation markers in children with congenital heart disease associated with pulmonary arterial hypertension. Congenit Heart Dis 13:506\u2013511","journal-title":"Congenit Heart Dis"},{"key":"2197_CR31","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1097\/MBC.0000000000000523","volume":"27","author":"A Remkova","year":"2016","unstructured":"Remkova A, Simkova I, Valkovicova T, Kaldararova M (2016) Platelet abnormalities in adults with severe pulmonary arterial hypertension related to congenital heart defects (Eisenmenger syndrome). Blood Coagul Fibrinolysis 27:925\u2013929","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2197_CR32","doi-asserted-by":"crossref","unstructured":"Nogueira-Ferreira R, Ferreira R, Henriques-Coelho T (2014) Cellular interplay in pulmonary arterial hypertension: implications for new therapies. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research. 1843:885\u201393.","DOI":"10.1016\/j.bbamcr.2014.01.030"},{"key":"2197_CR33","doi-asserted-by":"publisher","first-page":"L583","DOI":"10.1152\/ajplung.00321.2006","volume":"293","author":"RJ White","year":"2007","unstructured":"White RJ, Meoli DF, Swarthout RF, Kallop DY, Galaria II, Harvey JL et al (2007) Plexiform-like lesions and increased tissue factor expression in a rat model of severe pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 293:L583\u2013L590","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2197_CR34","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1161\/01.CIR.0000129312.43547.08","volume":"109","author":"P Cirillo","year":"2004","unstructured":"Cirillo P, Cali G, Golino P, Calabro P, Forte L, De Rosa S et al (2004) Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation. Circulation 109:2911\u20132916","journal-title":"Circulation"},{"key":"2197_CR35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1055\/s-0038-1650283","volume":"75","author":"Y Sato","year":"1996","unstructured":"Sato Y, Asada Y, Marutsuka K, Hatakeyama K, Sumiyoshi A (1996) Tissue factor induces migration of cultured aortic smooth muscle cells. Thromb Haemost 75:389\u2013392","journal-title":"Thromb Haemost"},{"key":"2197_CR36","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1164\/rccm.200706-840OC","volume":"177","author":"B Bakouboula","year":"2008","unstructured":"Bakouboula B, Morel O, Faure A, Zobairi F, Jesel L, Trinh A et al (2008) Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension. Am J Respir Crit Care Med 177:536\u2013543","journal-title":"Am J Respir Crit Care Med"},{"key":"2197_CR37","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/eci.12018","volume":"43","author":"S Nadaud","year":"2013","unstructured":"Nadaud S, Poirier O, Girerd B, Blanc C, Montani D, Eyries M et al (2013) Small platelet microparticle levels are increased in pulmonary arterial hypertension. Eur J Clin Invest 43:64\u201371","journal-title":"Eur J Clin Invest"},{"key":"2197_CR38","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1056\/NEJM199207093270202","volume":"327","author":"BW Christman","year":"1992","unstructured":"Christman BW, McPherson CD, Newman JH, King GA, Bernard GR, Groves BM et al (1992) An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 327:70\u201375","journal-title":"N Engl J Med"},{"key":"2197_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0014-2999(02)02734-6","volume":"459","author":"D Awabdy","year":"2003","unstructured":"Awabdy D, Bryan-Lluka LJ, Wanstall JC (2003) 5-Hydroxytryptamine and platelets: uptake and aggregation in hypoxic pulmonary hypertensive rats. Eur J Pharmacol 459:1\u20137","journal-title":"Eur J Pharmacol"},{"key":"2197_CR40","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/263663a0","volume":"263","author":"S Moncada","year":"1976","unstructured":"Moncada S, Gryglewski R, Bunting S, Vane JR (1976) An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263:663\u2013665","journal-title":"Nature"},{"key":"2197_CR41","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1161\/01.CIR.102.22.2720","volume":"102","author":"F Sakamaki","year":"2000","unstructured":"Sakamaki F, Kyotani S, Nagaya N, Sato N, Oya H, Satoh T et al (2000) Increased plasma P-selectin and decreased thrombomodulin in pulmonary arterial hypertension were improved by continuous prostacyclin therapy. Circulation 102:2720\u20132725","journal-title":"Circulation"},{"key":"2197_CR42","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1067\/mtc.2003.107","volume":"125","author":"M Hach\u00e9","year":"2003","unstructured":"Hach\u00e9 M, Denault A, B\u00e9lisle S, Robitaille D, Couture P, Sheridan P et al (2003) Inhaled epoprostenol (prostacyclin) and pulmonary hypertension before cardiac surgery. J Thorac Cardiovasc Surg 125:642\u2013649","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2197_CR43","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1161\/01.CIR.96.9.2782","volume":"96","author":"R Friedman","year":"1997","unstructured":"Friedman R, Mears JG, Barst RJ (1997) Continuous infusion of prostacyclin normalizes plasma markers of endothelial cell injury and platelet aggregation in primary pulmonary hypertension. Circulation 96:2782\u20132784","journal-title":"Circulation"},{"key":"2197_CR44","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/09537104.2016.1203406","volume":"28","author":"Q Hu","year":"2017","unstructured":"Hu Q, Cho MS, Thiagarajan P, Aung FM, Sood AK, Afshar-Kharghan V (2017) A small amount of cyclooxygenase 2 (COX2) is constitutively expressed in platelets. Platelets 28:99\u2013102","journal-title":"Platelets"},{"key":"2197_CR45","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0002-9343(99)80156-9","volume":"99","author":"P Herv\u00e9","year":"1995","unstructured":"Herv\u00e9 P, Launay J-M, Scrobohaci M-L, Brenot F, Simonneau G, Petitpretz P et al (1995) Increased plasma serotonin in primary pulmonary hypertension. Am J Med 99:249\u2013254","journal-title":"Am J Med"},{"key":"2197_CR46","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000314271","volume":"81","author":"S Ulrich","year":"2011","unstructured":"Ulrich S, Huber LC, Fischler M, Treder U, Maggiorini M, Eberli FR et al (2011) Platelet serotonin content and transpulmonary platelet serotonin gradient in patients with pulmonary hypertension. Respiration 81:211\u2013216","journal-title":"Respiration"},{"key":"2197_CR47","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1164\/rccm.200805-691OC","volume":"179","author":"C Guilluy","year":"2009","unstructured":"Guilluy C, Eddahibi S, Agard C, Guignabert C, Izikki M, Tu L et al (2009) RhoA and Rho kinase activation in human pulmonary hypertension: role of 5-HT signaling. Am J Respir Crit Care Med 179:1151\u20131158","journal-title":"Am J Respir Crit Care Med"},{"key":"2197_CR48","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3109\/01902148.2012.758191","volume":"39","author":"Y Liu","year":"2013","unstructured":"Liu Y, Tian H, Yan X, Fan F, Wang W, Han J (2013) Serotonin inhibits apoptosis of pulmonary artery smooth muscle cells through 5-HT2A receptors involved in the pulmonary artery remodeling of pulmonary artery hypertension. Exp Lung Res 39:70\u201379","journal-title":"Exp Lung Res"},{"key":"2197_CR49","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11010-014-2194-0","volume":"397","author":"C Chen","year":"2014","unstructured":"Chen C, Han X, Fan F, Liu Y, Wang T, Wang J et al (2014) Serotonin drives the activation of pulmonary artery adventitial fibroblasts and TGF-\u03b21\/Smad3-mediated fibrotic responses through 5-HT2A receptors. Mol Cell Biochem 397:267\u2013276","journal-title":"Mol Cell Biochem"},{"key":"2197_CR50","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1161\/CIRCRESAHA.114.303662","volume":"114","author":"EM Bauer","year":"2014","unstructured":"Bauer EM, Chanthaphavong RS, Sodhi CP, Hackam DJ, Billiar TR, Bauer PM (2014) Genetic deletion of toll-like receptor 4 on platelets attenuates experimental pulmonary hypertensionnovelty and significance. Circ Res 114:1596\u20131600","journal-title":"Circ Res"},{"key":"2197_CR51","doi-asserted-by":"crossref","unstructured":"Benza RL, Gomberg-Maitland M, Elliott CG, Farber HW, Foreman AJ, Frost AE et al (2019) Predicting survival in patients with pulmonary arterial hypertension: the REVEAL risk score calculator 2.0 and comparison with ESC\/ERS-based risk assessment strategies. Chest 156:323\u201337.","DOI":"10.1016\/j.chest.2019.02.004"},{"key":"2197_CR52","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1161\/CIRCULATIONAHA.113.004526","volume":"129","author":"KM Olsson","year":"2014","unstructured":"Olsson KM, Delcroix M, Ghofrani HA, Tiede H, Huscher D, Speich R et al (2014) Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA). Circulation 129:57\u201365","journal-title":"Circulation"},{"key":"2197_CR53","doi-asserted-by":"crossref","unstructured":"Hu Y, Chi L, Kuebler WM, Goldenberg NM (2020) Perivascular inflammation in pulmonary arterial hypertension. Cells 9.","DOI":"10.3390\/cells9112338"},{"key":"2197_CR54","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12890-017-0407-5","volume":"17","author":"L Harbaum","year":"2017","unstructured":"Harbaum L, Baaske KM, Simon M, Oqueka T, Sinning C, Glatzel A et al (2017) Exploratory analysis of the neutrophil to lymphocyte ratio in patients with pulmonary arterial hypertension. BMC Pulm Med 17:72","journal-title":"BMC Pulm Med"},{"key":"2197_CR55","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1177\/0300060515589394","volume":"43","author":"E Ozpelit","year":"2015","unstructured":"Ozpelit E, Akdeniz B, Ozpelit ME, Tas S, Bozkurt S, Tertemiz KC et al (2015) Prognostic value of neutrophil-to-lymphocyte ratio in pulmonary arterial hypertension. J Int Med Res 43:661\u2013671","journal-title":"J Int Med Res"},{"key":"2197_CR56","doi-asserted-by":"publisher","first-page":"229","DOI":"10.5761\/atcs.oa.14-00190","volume":"21","author":"M Yanartas","year":"2015","unstructured":"Yanartas M, Kalkan ME, Arslan A, Tas SG, Koksal C, Bekiroglu N et al (2015) Neutrophil\/lymphocyte ratio can predict postoperative mortality in patients with chronic thromboembolic pulmonary hypertension. Ann Thorac Cardiovasc Surg 21:229\u2013235","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"2197_CR57","doi-asserted-by":"publisher","first-page":"604","DOI":"10.5543\/tkda.2013.93385","volume":"41","author":"A Yildiz","year":"2013","unstructured":"Yildiz A, Kaya H, Ertas F, Oylumlu M, Bilik MZ, Yuksel M et al (2013) Association between neutrophil to lymphocyte ratio and pulmonary arterial hypertension. Turk Kardiyol Dern Ars 41:604\u2013609","journal-title":"Turk Kardiyol Dern Ars"},{"key":"2197_CR58","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.micinf.2003.09.008","volume":"5","author":"M Faurschou","year":"2003","unstructured":"Faurschou M, Borregaard N (2003) Neutrophil granules and secretory vesicles in inflammation. Microbes Infect 5:1317\u20131327","journal-title":"Microbes Infect"},{"key":"2197_CR59","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/76282","volume":"6","author":"KN Cowan","year":"2000","unstructured":"Cowan KN, Heilbut A, Humpl T, Lam C, Ito S, Rabinovitch M (2000) Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor. Nat Med 6:698\u2013702","journal-title":"Nat Med"},{"key":"2197_CR60","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1164\/rccm.201412-2291OC","volume":"191","author":"NP Nickel","year":"2015","unstructured":"Nickel NP, Spiekerkoetter E, Gu M, Li CG, Li H, Kaschwich M et al (2015) Elafin reverses pulmonary hypertension via caveolin-1-dependent bone morphogenetic protein signaling. Am J Respir Crit Care Med 191:1273\u20131286","journal-title":"Am J Respir Crit Care Med"},{"key":"2197_CR61","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/cmdc.201500269","volume":"11","author":"F von Nussbaum","year":"2016","unstructured":"von Nussbaum F, Li VM, Meibom D, Anlauf S, Bechem M, Delbeck M et al (2016) Potent and selective human neutrophil elastase inhibitors with novel equatorial ring topology: in vivo efficacy of the polar pyrimidopyridazine BAY-8040 in a pulmonary arterial hypertension rat model. ChemMedChem 11:199\u2013206","journal-title":"ChemMedChem"},{"key":"2197_CR62","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1161\/hc0402.102866","volume":"105","author":"SH Zaidi","year":"2002","unstructured":"Zaidi SH, You XM, Ciura S, Husain M, Rabinovitch M (2002) Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic pulmonary hypertension. Circulation 105:516\u2013521","journal-title":"Circulation"},{"key":"2197_CR63","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1160\/TH03-03-0173","volume":"90","author":"F Rose","year":"2003","unstructured":"Rose F, Hattar K, Gakisch S, Grimminger F, Olschewski H, Seeger W et al (2003) Increased neutrophil mediator release in patients with pulmonary hypertension\u2013suppression by inhaled iloprost. Thromb Haemost 90:1141\u20131149","journal-title":"Thromb Haemost"},{"key":"2197_CR64","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/j.ajpath.2011.05.051","volume":"179","author":"YM Kim","year":"2011","unstructured":"Kim YM, Haghighat L, Spiekerkoetter E, Sawada H, Alvira CM, Wang L et al (2011) Neutrophil elastase is produced by pulmonary artery smooth muscle cells and is linked to neointimal lesions. Am J Pathol 179:1560\u20131572","journal-title":"Am J Pathol"},{"key":"2197_CR65","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1016\/j.athoracsur.2013.07.017","volume":"96","author":"N Nomura","year":"2013","unstructured":"Nomura N, Asano M, Saito T, Nakayama T, Mishima A (2013) Sivelestat attenuates lung injury in surgery for congenital heart disease with pulmonary hypertension. Ann Thorac Surg 96:2184\u20132191","journal-title":"Ann Thorac Surg"},{"key":"2197_CR66","doi-asserted-by":"crossref","unstructured":"Klinke A, Berghausen E, Friedrichs K, Molz S, Lau D, Remane L et al (2018) Myeloperoxidase aggravates pulmonary arterial hypertension by activation of vascular Rho-kinase. JCI Insight 3.","DOI":"10.1172\/jci.insight.97530"},{"key":"2197_CR67","doi-asserted-by":"crossref","unstructured":"Do e Z, Fukumoto Y, Takaki A, Tawara S, Ohashi J, Nakano M et al (2009) Evidence for Rho-kinase activation in patients with pulmonary arterial hypertension. Circ J 73:1731\u20139.","DOI":"10.1253\/circj.CJ-09-0135"},{"key":"2197_CR68","doi-asserted-by":"crossref","unstructured":"Zimmer A, Teixeira RB, Constantin RL, Campos-Carraro C, Aparicio Cordero EA, Ortiz VD et al (2021) The progression of pulmonary arterial hypertension induced by monocrotaline is characterized by lung nitrosative and oxidative stress, and impaired pulmonary artery reactivity. Eur J Pharmacol 891:173699.","DOI":"10.1016\/j.ejphar.2020.173699"},{"key":"2197_CR69","doi-asserted-by":"crossref","unstructured":"Kitano K, Usui S, Ootsuji H, Takashima S, Kobayashi D, Murai H et al (2014) Rho-kinase activation in leukocytes plays a pivotal role in myocardial ischemia\/reperfusion injury. PLoS One 9:e92242.","DOI":"10.1371\/journal.pone.0092242"},{"key":"2197_CR70","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1161\/CIRCULATIONAHA.109.933762","volume":"122","author":"E Soon","year":"2010","unstructured":"Soon E, Holmes AM, Treacy CM, Doughty NJ, Southgate L, Machado RD et al (2010) Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation 122:920\u2013927","journal-title":"Circulation"},{"key":"2197_CR71","first-page":"H1713","volume":"260","author":"U Ikeda","year":"1991","unstructured":"Ikeda U, Ikeda M, Oohara T, Oguchi A, Kamitani T, Tsuruya Y et al (1991) Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner. Am J Physiol 260:H1713\u2013H1717","journal-title":"Am J Physiol"},{"key":"2197_CR72","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.4049\/jimmunol.170.6.3369","volume":"170","author":"A Li","year":"2003","unstructured":"Li A, Dubey S, Varney ML, Dave BJ, Singh RK (2003) IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 170:3369\u20133376","journal-title":"J Immunol"},{"issue":"Suppl 2","key":"2197_CR73","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1097\/00005344-199117002-00026","volume":"17","author":"S Morimoto","year":"1991","unstructured":"Morimoto S, Nabata T, Koh E, Shiraishi T, Fukuo K, Imanaka S et al (1991) Interleukin-6 stimulates proliferation of cultured vascular smooth muscle cells independently of interleukin-1 beta. J Cardiovasc Pharmacol 17(Suppl 2):S117\u2013S118","journal-title":"J Cardiovasc Pharmacol"},{"key":"2197_CR74","doi-asserted-by":"crossref","unstructured":"Hally KE, Parker OM, Brunton-O'Sullivan MM, Harding SA, Larsen PD (2021) Linking neutrophil extracellular traps and platelet activation: a composite biomarker score for predicting outcomes after acute myocardial infarction. Thromb Haemost","DOI":"10.1055\/s-0041-1728763"},{"key":"2197_CR75","doi-asserted-by":"crossref","unstructured":"Lim HH, Jeong IH, An GD, Woo KS, Kim KH, Kim JM et al (2020) Evaluation of neutrophil extracellular traps as the circulating marker for patients with acute coronary syndrome and acute ischemic stroke. J Clin Lab Anal 34:e23190.","DOI":"10.1002\/jcla.23190"},{"key":"2197_CR76","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1161\/STROKEAHA.119.026848","volume":"50","author":"C Pena-Martinez","year":"2019","unstructured":"Pena-Martinez C, Duran-Laforet V, Garcia-Culebras A, Ostos F, Hernandez-Jimenez M, Bravo-Ferrer I et al (2019) Pharmacological modulation of neutrophil extracellular traps reverses thrombotic stroke tPA (tissue-type plasminogen activator) resistance. Stroke 50:3228\u20133237","journal-title":"Stroke"},{"key":"2197_CR77","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1160\/TH17-02-0130","volume":"117","author":"J Valles","year":"2017","unstructured":"Valles J, Lago A, Santos MT, Latorre AM, Tembl JI, Salom JB et al (2017) Neutrophil extracellular traps are increased in patients with acute ischemic stroke: prognostic significance. Thromb Haemost 117:1919\u20131929","journal-title":"Thromb Haemost"},{"key":"2197_CR78","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1111\/jth.12710","volume":"12","author":"N Maugeri","year":"2014","unstructured":"Maugeri N, Campana L, Gavina M, Covino C, De Metrio M, Panciroli C et al (2014) Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps. J Thromb Haemost 12:2074\u20132088","journal-title":"J Thromb Haemost"},{"key":"2197_CR79","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1161\/ATVBAHA.113.301627","volume":"33","author":"JI Borissoff","year":"2013","unstructured":"Borissoff JI, Joosen IA, Versteylen MO, Brill A, Fuchs TA, Savchenko AS et al (2013) Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state. Arterioscler Thromb Vasc Biol 33:2032\u20132040","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2197_CR80","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1093\/eurheartj\/ehv007","volume":"36","author":"DA Stakos","year":"2015","unstructured":"Stakos DA, Kambas K, Konstantinidis T, Mitroulis I, Apostolidou E, Arelaki S et al (2015) Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction. Eur Heart J 36:1405\u20131414","journal-title":"Eur Heart J"},{"key":"2197_CR81","doi-asserted-by":"crossref","unstructured":"Zhou P, Li T, Jin J, Liu Y, Li B, Sun Q et al (2020) Interactions between neutrophil extracellular traps and activated platelets enhance procoagulant activity in acute stroke patients with ICA occlusion. EBioMedicine 53:102671.","DOI":"10.1016\/j.ebiom.2020.102671"},{"key":"2197_CR82","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/jth.12796","volume":"13","author":"M Jim\u00e9nez-Alc\u00e1zar","year":"2015","unstructured":"Jim\u00e9nez-Alc\u00e1zar M, Napirei M, Panda R, K\u00f6hler E, Kremer Hovinga JA, Mannherz H et al (2015) Impaired DNase1-mediated degradation of neutrophil extracellular traps is associated with acute thrombotic microangiopathies. J Thromb Haemost 13:732\u2013742","journal-title":"J Thromb Haemost"},{"key":"2197_CR83","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1084\/jem.20112322","volume":"209","author":"ML von Br\u00fchl","year":"2012","unstructured":"von Br\u00fchl ML, Stark K, Steinhart A, Chandraratne S, Konrad I, Lorenz M et al (2012) Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 209:819\u2013835","journal-title":"J Exp Med"},{"key":"2197_CR84","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1161\/ATVBAHA.118.311150","volume":"38","author":"EJ Folco","year":"2018","unstructured":"Folco EJ, Mawson TL, Vromman A, Bernardes-Souza B, Franck G, Persson O et al (2018) Neutrophil extracellular traps induce endothelial cell activation and tissue factor production through interleukin-1alpha and cathepsin G. Arterioscler Thromb Vasc Biol 38:1901\u20131912","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2197_CR85","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.thromres.2015.10.012","volume":"137","author":"X Yang","year":"2016","unstructured":"Yang X, Li L, Liu J, Lv B, Chen F (2016) Extracellular histones induce tissue factor expression in vascular endothelial cells via TLR and activation of NF-\u03baB and AP-1. Thromb Res 137:211\u2013218","journal-title":"Thromb Res"},{"key":"2197_CR86","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1182\/blood-2012-06-437772","volume":"120","author":"R Darbousset","year":"2012","unstructured":"Darbousset R, Thomas GM, Mezouar S, Fr\u00e8re C, Bonier R, Mackman N et al (2012) Tissue factor\u2013positive neutrophils bind to injured endothelial wall and initiate thrombus formation. Blood 120:2133\u20132143","journal-title":"Blood"},{"key":"2197_CR87","doi-asserted-by":"crossref","unstructured":"Kim JE, Yoo HJ, Gu JY, Kim HK (2016) Histones induce the procoagulant phenotype of endothelial cells through tissue factor up-regulation and thrombomodulin down-regulation. PloS one 11:e0156763.","DOI":"10.1371\/journal.pone.0156763"},{"key":"2197_CR88","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.1038\/s41598-018-22156-5","volume":"8","author":"Y Wang","year":"2018","unstructured":"Wang Y, Luo L, Braun OO, Westman J, Madhi R, Herwald H et al (2018) Neutrophil extracellular trap-microparticle complexes enhance thrombin generation via the intrinsic pathway of coagulation in mice. Sci Rep 8:4020","journal-title":"Sci Rep"},{"key":"2197_CR89","doi-asserted-by":"crossref","unstructured":"Vallance TM, Zeuner M-T, Williams HF, Widera D, Vaiyapuri S (2017) Toll-like receptor 4 signalling and its impact on platelet function, thrombosis, and haemostasis. Mediat Inflamm\u00a02017.","DOI":"10.1155\/2017\/9605894"},{"key":"2197_CR90","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1182\/blood-2011-03-343061","volume":"118","author":"F Semeraro","year":"2011","unstructured":"Semeraro F, Ammollo CT, Morrissey JH, Dale GL, Friese P, Esmon NL et al (2011) Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood 118:1952\u20131961","journal-title":"Blood"},{"key":"2197_CR91","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/ni1491","volume":"8","author":"H-B Wang","year":"2007","unstructured":"Wang H-B, Wang J-T, Zhang L, Geng ZH, Xu W-L, Xu T et al (2007) P-selectin primes leukocyte integrin activation during inflammation. Nat Immunol 8:882","journal-title":"Nat Immunol"},{"key":"2197_CR92","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/cvr\/cvv154","volume":"107","author":"RP McEver","year":"2015","unstructured":"McEver RP (2015) Selectins: initiators of leucocyte adhesion and signalling at the vascular wall. Cardiovasc Res 107:331\u2013339","journal-title":"Cardiovasc Res"},{"key":"2197_CR93","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1182\/blood-2013-07-516484","volume":"123","author":"J Rossaint","year":"2014","unstructured":"Rossaint J, Herter JM, Van Aken H, Napirei M, D\u00f6ring Y, Weber C et al (2014) Synchronized integrin engagement and chemokine activation is crucial in neutrophil extracellular trap\u2013mediated sterile inflammation. Blood 123:2573\u20132584","journal-title":"Blood"},{"key":"2197_CR94","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1189\/jlb.3A0415-161R","volume":"99","author":"A Carestia","year":"2016","unstructured":"Carestia A, Kaufman T, Rivadeneyra L, Landoni VI, Pozner RG, Negrotto S et al (2016) Mediators and molecular pathways involved in the regulation of neutrophil extracellular trap formation mediated by activated platelets. J Leukoc Biol 99:153\u2013162","journal-title":"J Leukoc Biol"},{"key":"2197_CR95","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1186\/s13054-020-03082-3","volume":"24","author":"Y Jiao","year":"2020","unstructured":"Jiao Y, Li W, Wang W, Tong X, Xia R, Fan J et al (2020) Platelet-derived exosomes promote neutrophil extracellular trap formation during septic shock. Crit Care 24:380","journal-title":"Crit Care"},{"key":"2197_CR96","doi-asserted-by":"publisher","first-page":"L342","DOI":"10.1152\/ajplung.00151.2012","volume":"304","author":"JM Tadie","year":"2013","unstructured":"Tadie JM, Bae HB, Jiang S, Park DW, Bell CP, Yang H et al (2013) HMGB1 promotes neutrophil extracellular trap formation through interactions with Toll-like receptor 4. Am J Physiol Lung Cell Mol Physiol 304:L342\u2013L349","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2197_CR97","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1111\/bph.14765","volume":"176","author":"Y Wang","year":"2019","unstructured":"Wang Y, Du F, Hawez A, Morgelin M, Thorlacius H (2019) Neutrophil extracellular trap-microparticle complexes trigger neutrophil recruitment via high-mobility group protein 1 (HMGB1)-toll-like receptors(TLR2)\/TLR4 signalling. Br J Pharmacol 176:3350\u20133363","journal-title":"Br J Pharmacol"},{"key":"2197_CR98","doi-asserted-by":"crossref","unstructured":"Lam FW, Cruz MA, Parikh K, Rumbaut RE (2016) Histones stimulate von Willebrand factor release in vitro and in vivo. Haematologica 101:e277-e9.","DOI":"10.3324\/haematol.2015.140632"},{"key":"2197_CR99","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1161\/ATVBAHA.113.303016","volume":"34","author":"S Grassle","year":"2014","unstructured":"Grassle S, Huck V, Pappelbaum KI, Gorzelanny C, Aponte-Santamaria C, Baldauf C et al (2014) von Willebrand factor directly interacts with DNA from neutrophil extracellular traps. Arterioscler Thromb Vasc Biol 34:1382\u20131389","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2197_CR100","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1136\/annrheumdis-2013-204837","volume":"74","author":"C Carmona-Rivera","year":"2015","unstructured":"Carmona-Rivera C, Zhao W, Yalavarthi S, Kaplan MJ (2015) Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2. Ann Rheum Dis 74:1417\u20131424","journal-title":"Ann Rheum Dis"},{"key":"2197_CR101","doi-asserted-by":"crossref","unstructured":"Saffarzadeh M, Juenemann C, Queisser MA, Lochnit G, Barreto G, Galuska SP et al (2012) Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS One 7:e32366.","DOI":"10.1371\/journal.pone.0032366"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-022-02197-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-022-02197-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-022-02197-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T06:35:49Z","timestamp":1700462149000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-022-02197-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,20]]},"references-count":101,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["2197"],"URL":"https:\/\/doi.org\/10.1007\/s00109-022-02197-0","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,20]]},"assertion":[{"value":"23 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}